Literature DB >> 8972019

Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-kappa B/c-Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alfa (TNF-alpha) in human monocytes.

L T Osnes1, K B Foss, G B Joø, C Okkenhaug, A B Westvik, R Ovstebø, P Kierulf.   

Abstract

We have investigated the effects of acetylsalicylic acid and sodium salicylate on the LPS-induced synthesis of the pro-coagulant protein tissue factor (TF) and the pro-inflammatory protein tumor necrosis factor-alpha (TNF-alpha), as well as the prostaglandin PGE2 in human monocytes. Both drugs dose-dependently inhibited LPS-induced TF and TNF-alpha synthesis at the mRNA and the protein level, and reduced PGE2 production. As evidenced by electro mobility shift assay (EMSA) and the use of a NF-kappa B prototypic probe, these drugs probably exert their inhibitory effects by interference with the nuclear translocation of NF-kappa B/c-Rel proteins. These data may expand the understanding of the anti-thrombotic and anti-inflammatory effects of these drugs when activation of monocytes occurs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8972019

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  13 in total

Review 1.  Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction.

Authors:  U N Das
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

Review 2.  Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions.

Authors:  Anetta Undas; Kathleen E Brummel-Ziedins; Kenneth G Mann
Journal:  Blood       Date:  2006-12-05       Impact factor: 22.113

3.  Mitochondrial mitophagy protection combining rivaroxaban and aspirin in high glucose-exposed human coronary artery endothelial cell. An in vitro study.

Authors:  Khaoula Zekri-Nechar; José Javier Zamorano-León; Mercedes Cortina-Gredilla; Ana López-de-Andrés; Rodrigo Jiménez-García; Carlos Navarro-Cuellar; Antonio López-Farré; Carlos Hugo Martínez-Martínez
Journal:  Diab Vasc Dis Res       Date:  2022 Sep-Oct       Impact factor: 3.541

4.  NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes.

Authors:  P Minuz; M Degan; S Gaino; A Meneguzzi; V Zuliani; C L Santonastaso; P D Soldato; A Lechi
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

5.  Potent analgesic and anti-inflammatory actions of a novel thymulin-related peptide in the rat.

Authors:  Bared Safieh-Garabedian; Mireille Dardenne; Jean Marie Pléau; Nayef E Saadé
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

Review 6.  Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation.

Authors:  Hideo Yoshida; D Neil Granger
Journal:  Inflamm Bowel Dis       Date:  2009-08       Impact factor: 5.325

7.  Release of tumor necrosis factor-alpha and prostanoids in whole blood cultures after in vivo exposure to low-dose aspirin.

Authors:  I Beckmann; S Ben-Efraim; M Vervoort; H C Wallenburg
Journal:  Mediators Inflamm       Date:  2001-04       Impact factor: 4.711

8.  A novel hybrid aspirin-NO-releasing compound inhibits TNFalpha release from LPS-activated human monocytes and macrophages.

Authors:  Catriona M Turnbull; Paolo Marcarino; Tara A Sheldrake; Loretta Lazzarato; Clara Cena; Roberta Fruttero; Alberto Gasco; Sarah Fox; Ian L Megson; Adriano G Rossi
Journal:  J Inflamm (Lond)       Date:  2008-07-31       Impact factor: 4.981

9.  Proinflammatory and Anti-Inflammatory Cytokines Mediated by NF-κB Factor as Prognostic Markers in Mammary Tumors.

Authors:  Gustavo Rodrigues Martins; Gabriela Bottaro Gelaleti; Marina Gobbe Moschetta; Larissa Bazela Maschio-Signorini; Debora Ap Pires de Campos Zuccari
Journal:  Mediators Inflamm       Date:  2016-02-16       Impact factor: 4.711

10.  Markers of hypercoagulability in CAD patients. Effects of single aspirin and clopidogrel treatment.

Authors:  Vibeke Bratseth; Alf-Åge Pettersen; Trine B Opstad; Harald Arnesen; Ingebjørg Seljeflot
Journal:  Thromb J       Date:  2012-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.